These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8547469)

  • 41. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
    Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
    Kaufmann M; Jonat W; Schachner-Wünschmann E; Bastert G; Maass H
    Onkologie; 1991 Feb; 14(1):22-4, 26-8, 30. PubMed ID: 1829149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
    Elkind-Hirsch KE; Anania C; Malinak R
    J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors.
    Beamer WG
    J Natl Cancer Inst; 1986 Nov; 77(5):1117-23. PubMed ID: 3095581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Appropriate prolongation of GnRH-a down-regulation improves the synchronism of follicular development].
    Wang B; Sun HX; Liu JY; Hu YL; He FF
    Zhonghua Nan Ke Xue; 2011 Dec; 17(12):1087-91. PubMed ID: 22235676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Luteinizing hormone release after administration of the gonadotropin-releasing hormone agonist Fertilan (goserelin) for synchronization of ovulation in pigs.
    Brüssow KP; Schneider F; Tuchscherer A; Rátky J; Kraeling RR; Kanitz W
    J Anim Sci; 2007 Jan; 85(1):129-37. PubMed ID: 17179548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy.
    Franke HR; Smit WM; Vermes I
    Gynecol Endocrinol; 2005 May; 20(5):274-8. PubMed ID: 16019373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulsatile administration of gonadotropin-releasing hormone agonist to gilts actively immunized against gonadotropin-releasing hormone.
    Traywick GB; Esbenshade KL
    J Anim Sci; 1988 Sep; 66(9):2209-15. PubMed ID: 3139608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pituitary gonadotropin-releasing hormone receptor content in rats with polycystic ovaries.
    Carriere PD; Brawer JR; Farookhi R
    Biol Reprod; 1988 Apr; 38(3):562-7. PubMed ID: 2837294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Continuous gonadotropin-releasing hormone infusion stimulates dramatic gonadal development in hypogonadal female mice.
    Gibson MJ; Kasowski H; Dobrjansky A
    Biol Reprod; 1994 Mar; 50(3):680-5. PubMed ID: 8167240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Zoladex as a depot GnRH agonist in premenopausal metastatic breast cancer].
    Schmid H; Schachner-Wünschmann E; Kaufmann M
    Arch Gynecol Obstet; 1989; 245(1-4):741-3. PubMed ID: 2529825
    [No Abstract]   [Full Text] [Related]  

  • 55. Structure-function correlations of human pituitary gonadotroph adenomas in vitro.
    Asa SL; Gerrie BM; Kovacs K; Horvath E; Singer W; Killinger DW; Smyth HS
    Lab Invest; 1988 Apr; 58(4):403-10. PubMed ID: 2451766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gonadotropin secretion and pituitary responsiveness to GnRH in mares with granulosa-theca cell tumor.
    Zelli R; Sylla L; Monaci M; Stradaioli G; Sibley LE; Roser JF; Munro C; Liu IK
    Theriogenology; 2006 Sep; 66(5):1210-8. PubMed ID: 16647750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice.
    Danilovich N; Roy I; Sairam MR
    Endocrinology; 2001 Aug; 142(8):3673-84. PubMed ID: 11459817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of gonadotropin-releasing hormone (GnRH) pulse frequency on serum and pituitary concentrations of luteinizing hormone and follicle-stimulating hormone, GnRH receptors, and messenger ribonucleic acid for gonadotropin subunits in cows.
    Vizcarra JA; Wettemann RP; Braden TD; Turzillo AM; Nett TM
    Endocrinology; 1997 Feb; 138(2):594-601. PubMed ID: 9002991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential suppression of FSH and LH secretion by follicular fluid in the presence or absence of GnRH.
    Charlesworth MC; Grady RR; Shin L; Vale WW; Rivier C; Rivier J; Schwartz NB
    Neuroendocrinology; 1984 Mar; 38(3):199-205. PubMed ID: 6425710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.